Dr. Matthew J. Eagleton, MD
Vascular Surgery (Vascular Surgery Physician)
- Medicare participating
At a glance
- Years since graduation
- 32
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 556
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Vascular Surgery Physician primary
MA license 273462 · NH license 20252 -
Surgery Physician
MA license 273462
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Brigham and Women's Hospital Boston, MA
- Massachusetts General Hospital Boston, MA
- North Shore Medical Center - Salem, MA
- Wentworth-Douglass Hospital Dover, NH
- Cooley Dickinson Hospital Inc,the Northampton, MA
Medical groups
- Massachusetts General Physicians Organization Inc (3,558 clinicians)
- Brigham and Womens Physicians Organization Inc (2,994 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 556
- Services billed
- 863
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 10-19 minutes | 116 | 95 |
| Complete ultrasound study of arm and leg arteries | 110 | 108 |
| Established patient office or other outpatient visit, 20-29 minutes | 104 | 98 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 73 | 71 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 49 | 49 |
| Ultrasound of both sides of head and neck blood flow | 20 | 20 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 19 | 18 |
| Ultrasound of one leg arteries or artery grafts | 19 | 18 |
| New patient office or other outpatient visit, 45-59 minutes | 18 | 18 |
| New patient office or other outpatient visit, 60-74 minutes | 18 | 18 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 5 companies reported 8 payments worth $1,046 in total to this clinician.
| W. L. Gore & Associates, Inc. | $473 |
|---|---|
| Bolton Medical Inc | $222 |
| Penumbra, Inc. | $148 |
| Boston Scientific Corporation | $137 |
| Centerline Biomedical Inc. | $65.66 |
| Food and Beverage | $1,046 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 5 industry-funded studies in 2025, from 3 companies. The companies reported $120,462 in research payments for these studies, mostly to the institutions running them.
- US Aortic Research Consortium (US ARC)
Cook Research Incorporated - AAA-SHAPE Pivotal Trial: Abdominal Aortic Aneurysm Sac Healing and Prevention of Expansion
Shape Memory Medical Inc. · NCT06029667 - Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms
W. L. Gore & Associates, Inc. · Active, not recruiting · NCT03728985 - Zenith Fenestrated+ Endovascular Graft Clinical Study
Cook Research Incorporated - Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 2
W. L. Gore & Associates, Inc. · Active, not recruiting · NCT02777593
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.